NSAID exposure delays time-to-pregnancy in patients with spondyloarthritis: an analysis of the GR2 prospective cohort
Authors:
- Sabrina HamrounSHSabrina Hamroun
- Marion CoudercMCMarion Couderc
- René-Marc FlipoRFRené-Marc Flipo
- Jérémie SellamJSJérémie Sellam
- Christophe RichezCRChristophe Richez
- Emanuelle DernisEDEmanuelle Dernis
- Aline FrazierAFAline Frazier
- Laure GossecLGLaure Gossec
- Elisabeth GervaisEGElisabeth Gervais
- Hubert MarotteHMHubert Marotte
- Laetitia DunogeantLDLaetitia Dunogeant
- Cédric LukasCLCédric Lukas
Open Access
Abstract
Background The impact of disease activity and treatment on fertility outcomes in patients with spondyloarthritis (SpA) has been little explored. This study aimed to describe median time to pregnancy (TTP) in women with SpA and the factors influencing TTP in this population. Methods This prospective observational multicentre (63 centres) French cohort (GR2 study—NCT02450396) included consecutive women with a diagnosis of SpA (according to their rheumatologist) who wanted to become pregnant between 2015 and 2021. TTP (in months) was the main outcome criterion, prospectively calculated from the date of study inclusion to the date of conception. Data on demographics, disease characteristics, disease activity, severity and treatment were prospectively collected at inclusion and each year thereafter until pregnancy occurred. TTP and its associated factors were estimated by survival analysis (Shared Frailty Cox models), with a random centre effect and multiple imputation to address missing data. Results We analysed 88 women included before conception. Among them, 56 (63.6%) became pregnant during follow-up. Median TTP was 16.1 (95% CI (12.2 to 25.3)) months. Mean preconceptional Bath Ankylosing Spondylitis Disease Activity Index at inclusion was 2.9 (±SD 2.1). Patients were treated with TNF inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), conventional synthetic disease-modifying antirheumatic drugs and glucocorticoids in 61 (69.3%), 23 (26.1%), 12 (13.6%) and 8 (9.1%) cases, respectively. The multivariate model found a significant association between TTP and age (HR) (per year) 1.22 95% CI (1.08 to 1.40); pConclusion Age and NSAID use during preconception were significantly associated with a longer TTP, after adjustment for other confounding factors. These findings warrant caution in the use of NSAIDs in SpA patients trying to conceive.Keywords
This publication has 61 references indexed in Scilit:
- Ovarian reserve in patients with ankylosing spondylitisArchives of Gynecology and Obstetrics, 2020
- Factors Associated With Time to Pregnancy in Women With Axial Spondyloarthritis: A Registry‐Based Multicenter StudyArthritis Care & Research, 2020
- 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal DiseasesArthritis Care & Research, 2020
- Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothersClinical Rheumatology, 2019
- Brief Report: Nonsteroidal Antiinflammatory Drug–Sparing Effect of Tumor Necrosis Factor Inhibitors in Early Axial Spondyloarthritis: Results From the DESIR CohortArthritis & Rheumatology, 2015
- Levels of Serum Anti–Müllerian Hormone, a Marker for Ovarian Reserve, in Women With Rheumatoid ArthritisArthritis Care & Research, 2013
- Prevalence of axial spondylarthritis in the United States: Estimates from a cross‐sectional surveyArthritis Care & Research, 2012
- Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: Example of etanercept in advanced ankylosing spondylitisArthritis Care & Research, 2011
- Luteinized unruptured follicle syndrome increased by inactive disease and selective cyclooxygenase 2 inhibitors in women with inflammatory arthropathiesArthritis Care & Research, 2011
- Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trialArthritis & Rheumatism, 2005